Wednesday, July 8, 2026

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi

1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Clinical program

Anakinra 100mg and Placebo Depo-Medrone

Phase 3 · small molecule · Gout

Anakinra 100mg and Placebo Depo-Medrone for Gout is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

← All United Therapeutics Europe Ltd projects Phase 3 small molecule completed

Internal code P0850

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
United Therapeutics Europe Ltd
Phase
Phase 3
Modality
small_molecule
Indication
Gout
Status
completed
Trials
1